What are Antibody Biopharmaceuticals?
Antibody biopharmaceuticals are biologics made of antibodies which are proteins produced by our immune system when fighting off infections such as germs and viruses. The most distinctive characteristic of antibodies is their ability to bind specifically to their target antigens. This characteristic allows antibody biopharmaceuticals to act precisely on the lesion site, pathogens or cells that require treatment, resulting in superior treatment effectiveness and fewer side effects compared to existing chemical drugs.
What are Antibody Biosimilars?
Antibody biosimilars are biologics that have no clinical differences in terms of quality, efficacy and safety from original biologics. Celltrion successfully developed the world's 1st mAb biosimilar which is considered effective and affordable.
